Lien de connexion cliquez ici 

Annual Meeting— online meeting via TEAMS Thursday May 27, 2021

14h55—15h00 Welcome and introduction— Prof. Dr. K. Claes, president BVN-SBN
Clinical Research
Chair: F. Jouret & P. Janssens

15h00—15h10 Patterns of renal osteodystrophy one year after kidney transplantation.
H. Skou Jørgensen, G. Behets, P. D’Haese, P. Evenepoel

15h10—15h20 Robot-Assisted Management of Ureteral Complications in Kidney Transplant Patients.
J. Vangeneugden, C. Van Praet, L. Desender, C. Randon, S. Van Laecke, P. Peeters, E. Nagler, J. Vanmassenhove, K. Decaestecker

15h20—15h30 ILLUMINATE-B, a Phase 3 open-label study to evaluate lumasiran, an RNAi therapeutic, in young children with primary hyperoxaluria type 1 (PH1).
A. Devresse, G. Deschenes, P. Cochat, D. Magen, W. van’t Hoff, M. Michael, D. Sas, G. Schalk, H. Shasha-Lavsky, W. Hayes, K. Bae, A. Seddighzadeh, P. Garg, A. Vaishnaw, T. McGregor, K. Fujita, Y. Frishberg

15h30—15h40 ADPedKD: A global online platform to explore the childhood phenotype of Autosomal Dominant Polycystic Kidney Disease.
A. Dachy, S. De Rechter, L.M. Guay-Woodford, A.J. Mallet, T. Harris, D. Bockenhauer, F. Schaefer, M.C. Liebau, D. Mekahli on behalf the ADPedKD consortium

15h40—15h50 The serum levels of anti-sars-cov-2 antibodies remain detectable at 9 months post covid-19 in systematically screened kidney transplant recipients.
L. Firket, P. Huynen, A. Bouquegneau, C. Bonvoisin, S. Grosch, F. Jouret, L. Weekers

15h50– 16h00 Risk for excessive anticoagulation during hemodialysis is associated with type of vascular access and bedside coagulation testing: results of a cross-sectional study.
M. De Troyer, K. M. Wissing, D. De Clerck, M-L Cambier, T. Robberechts, K. François

16h00—16h10 Psychological wellbeing in parents of children with chronic kidney disease.
E. De Bruyne, S. Eloot, J. Vande Walle, A. Raes, W. Van Biesen, L. Goubert, E. Snauwaert, E. Van Hoecke

16h10—16h20 Patients with severe lactic acidosis on the ICU: retrospective study of contributing factors and impact of renal replacement therapy.
L. Van De Ginste, F. Vanommeslaeghe, E. Hoste, J. Krusec, W. Van Biesen, F. Verbeke

16h20—16h30 Prevalence and risk factors of sickle cell nephropathy in children living in a low-resource setting.
O. C. Adebayo, DM K. Betukumesu, A.B. Nkoy, P.M. Ekulu, L.P. Van den Heuvel, V. Labarque, E. Levtchenko

16h30—16h40 Illness-related stress in parents of children with Chronic Kidney Disease and associations with child Quality of Life.
L. Willem, N. Knops, D. Mekahli, E. De Bruyne, J. Vande Walle, A. Raes, S. Reynaert, D. Trouet, K. Van Hoeck, S. Vankerckhove, J. Assenmaker, B. Adams, S. Leroi, L. Collard, A. Michaux, N. Godefroid, E. Levtchenko

16h40—17h00 BREAK + possibility to ‘meet’ the sponsors
Clinical Experimental Research
Chair: S. Van Laecke & L. Heylen

17h00—17h10 MTOR-activating mutations in rragd cause kidney tubulopathy and cardiomyopathy (kica) syndrome.
K. Schlingmann, F. Jouret K. Shen, A. Nigam, F. Arjona, C. Dafinger, P. Houillier, D. Jones, F. Kleinerüschkamp, J. Oh, N. Godefroid, M. Eltan, T. Güran, S. Burtey, M-C Parotte, J. König, A. Braun, C. Bos, M. Ibars Serra, H. Rehmann, F. Zwartkruis, K. Renkema, K. Klingel, E. Schulze-Bahr, B. Schermer, C. Bergmann, J. Altmüller, H. Thiele, B. Beck, K. Dahan, D. Sabatini, M. Liebau, R. Vargas-Poussou, N. Knoers, M. Konrad, J. de Baaij

17h10—17h20 Peripheral blood transcriptomics demonstrate great potential in unraveling pathophysiological pathways of kidney allograft pathology.
E. Van Loon, W. Gwinner, D. Anglicheau, P. Marquet, M. Naesens

17h20—17h30 Sparse intragraft molecular classifiers for antibody-mediated and T-cell mediated kidney transplant rejection: development and validation.
J. Callemeyn, J. Manik Nava Sedeno, W. Gwinner, D. Anglicheau4, P. Marquet, A. Deutsch, H. Hatzikirou, M. Naesens

17h30—17h40 Gut microbiota and their derived metabolites, a search for potential targets to limit accumulation of protein-bound uremic toxins in chronic kidney diseaseM. Steenbeke, S. Valkenburg, W. Van Biesen, J.R. Delanghe, M.M. Speeckaert, G. Glorieux

17h40—17h50 Peripheral blood inflammatory chemokines uncover allo-immune inflammation in the absence of histological lesions.
E. Van Loon, T. Barba, B. Lamarthée, A. Senev, O. Thaunat, D. Schols, M. Naesens
Basic Research
Chair: S. Van Laecke & L. Heylen

17h50—18h00 Exposure to the toxic calcineurin-inhibitor cyclosporine, but not dehydration, mimics histopathology of chronic interstitial nephritis in agricultural communities.
G. Schreurs,S. Maudsley, C. Nast, M. De Broe, B. Vervaet

18h00—18h10 Delayed nephrectomy after unilateral ischemia enhances epithelial repair by stimulating proliferation of renal progenitor cells.
L. Moonen, E. Lazzeri, A. J. Peired, C. Conte, P. Romagnani, P. C. D’Haese, B.A. Vervaet

18h10—18h20 Metformin treatment is able to halt the progression of established non-diabetic chronic kidney disease in rats.
R. Corremans, E. Neven, P. C. D’Haese, B. A. Vervaet, A. Verhulst
18h20—18h30 Potential of urine-derived kidney progenitor cells for disease modeling in cystinosis and as target for gene therapy.
K. Veys, D. David, T. Bondue, S. Princiero Berlingerio, A. Reda, K. Held, J. Vriens, L. van den Heuvel, R. Gijsbers, F. Oliveira Arcolino, E. Levtchenko

18h30—18h40 Renal and extra renal manifestations in adult zebrafish model of cystinosis.
S. P. Berlingerio, J. He, L. de Groef, P. Baatsen, S. Cairoli, B. Goffredo, B. van den Heuvel, H. J Baelde, E. Levtchenko

18h40—19h00 BREAK + possibility to ‘meet’ the sponsors

Case Report / Case series
Chair: F. Jouret & P. Janssens
19h00—19h10 A rare cause of distributive shock in a patient treated with flucloxacillin.
C. Martens, P. Evenepoel, K. Claes, B. Meijers, K. De Vusser, A. Van Craenenbroeck, D. Kuypers, B. Bammens
19h10—19h20 Heparin-grafted dialyzer use is safe in case of heparin-induced thrombocytopenia.
K. François, C. Orlando, K. Jochmans, D. De Clerck, M-L Cambier, T. Robberechts, L. Pipeleers, P. Janssens, K. M. Wissing
19h20—19h30 Rescue plasmapheresis for massive shear-stress induced hemolysis following closure of a paravalvular leak.
T. Couck, P. De Meester, K. Claes, C. Vandenbriele
19h30—19h40 General assembly (members only)

 Info: [email protected]  Website: www.bvn-sbn.be

e-Posters
e-Posters and abstracts will be available as PDF @ www.bvn-sbn.be for one year, when permitted by the presenter.

1. Contribution of measuring complement regulatory factors in blood as part of the evaluation of patients with thrombotic microangiopathy S. Bisselele, P. Stordeur, J. Smet, J. Gleeson, D. Abramowicz, A. Massart

2. The choice between deceased and living donor kidney transplantation in children and adolescents: a multicentric cross-sectional study. L. Dierickx, L. Willem, A. Raes, K. Van Hoeck, K. Van Cauwenberghe, J. Vande Walle, E. Swauwaert, E. Levtchenko, N. Knops, A. Prytula

3. Variability of bioimpedance measurements in hemodialysis patients. F.Collart, M.Taghavi, T.Salaouatchi, G.Musigazi, M.Mesquita

4. Renal outcome and life expectancy in a Belgian elderly population with chronic kidney failure; a retrospective study. R. Vleut, L. de Waele, K. Wouters, R. Hellemans, A. Massart, E. Philipse, K. Leyssens, D. Abramowicz, M.M. Couttenye

5. “Is polyomavirus associated nephropathy more common in kidney transplant recipients exposed to valganciclovir?” ~ A retrospective single center analysis ~ A. Bertels, K. Wouters, V. Wijtvliet, A. Massart, K. Bergs, V. Mattheeussen, D. Abramowicz, R. Hellemans

6. Human stool metabolome differs upon 24-hour blood pressure levels and blood ressure dipping status: a prespective longitudinal study. J. Huart, A. Cirillo, B. Taminiau, J. Descy, A. Saint-Remy, G. Daube, JM Krzesinski, P. Melin, P. de Tullio, F. Jouret

7. Colon transporters in chronic kidney disease: a potential target to reduce microbiome-derived uremic toxins? M. Lauriola, S. Dejongh, B. Meijers

8. Effect of kidney stone prevention on urinary risk factors for kidney stone formation and new stone formation: a single centre retrospective cohort study. F. Janssens, C. Tielemans, L. Vonckx, KM. Wissing, E. Van de Perre

9. Dietary fibre intake is associated with serum levels of uraemic toxins in children with Chronic Kidney Disease. A. El Amouri, E. Snauwaert, A. Foulon, C. Vande Moortel, M. Van Dyck, K. Van Hoeck, N. Godefroid, G. Glorieux, W. Van Biesen, J. Vande Walle, A. Raes, S. Eloot

10. Peritoneal dialysis initiation to treat end stage kidney disease during pregnancy: a report of 2 cases. L. Jacobs, S. Kaysi, M. Mesquita, C. Fosso, A. Carlin, I. Brayer, M. Dratwa.

11. A kinetics based algorithm to treat acute neonatal hyperammonemia. E. Snauwaert, J. De Rudder, P. Verloo, E. Dhont, A. Raes, W. Van Biesen, S. Eloot

12. Systematic screening for sars-cov-2 s1/s2 antibodies helps to better assess the real incidence of covid-19 in kidney transplant recipients. L. Firket, P. Huynen, C. Bonvoisin, A. Bouquegneau, M-H Delbouille, S. Grosch, F. Jouret, L. Weekers

 Info: [email protected]  Website: www.bvn-sbn.be

13. Timing and duration of pre-transplant screening for renal transplantation: Reasons for delay and room for improvement. M. Dirix, E. Philipse, R. Vleut, V. Hartman, B. Bracke, T. Chapelle, G. Roeyen, D. Ysebaert, G. Van Beeumen, A. Massart, K. Leyssens, M.M. Couttenye, D. Abramowicz, R. Hellemans

14. Functional paracelular permeability of the colon in rats with kidney disease. S. Dejongh, M. Lauriola, R. Farré, B. Meijers

15. Mysterious diagnosis in a child with failure to thrive. A. Matthys, L. Gheuens, S. Karamaria, A. Prytula, E. Snauwaert, L. Dossche, J. Vande Walle, J. Dehoorne, A. Raes

16. Reduced incidence of treated kidney failure (KF)) in 2020 : a Covid-19 effect ? L.Jacobs, F.Collart, T.Baudoux, C.Bonvoisin, JM De Smet, A Devresse, J Mbaba, L Radermacher, JM des Grottes

17. Chronic acetaminophen use: a rare but emerging cause of 5-oxoproline-induced increased anion gap metabolic acidosis. E. Devolder, W. Rosseel, A. Van Der Veen, M. Van Hemelen, P. Verschueren, A. Wilmer , P. Vermeersch, K. Claes

18. 12-Month Analysis of ILLUMINATE-A, a Phase 3 Study of Lumasiran: Sustained Oxalate Lowering and Kidney Stone Event Rates in Primary Hyperoxaluria Type 1 A. Devresse1, J. M Saland, J. Groothoff, Y. Frishberg, S-A Hulton, M. Koren, J. Scott Overcash, A-L Sellier-Leclerc, G. Deschenes, H. Shasha-Lavsky, W. Hayes, D. Fuster, D. Magen, S. H Moochhala, M. Coenen, E. Simkova, S.F Garrelfs, D.J, Sas, K. Meliambro, T. Ngo, K. Fujit8, J.M Gansner, T.L McGregor, J. C Lieske

19. The irradiation-induced renal ischemic preconditioning is blunted by the oral administration of the anti-angiogenic agent, sunitinib B. Khbouz, F. Lallemand, P.l Rowart, L. Poma, JM Krezenski, N. Eddine Sounni, A. Noel, F. Jouret

20. ADPKD, cytopenia and transplant outcomes. P. Schellekens, D. Mekahli, I. Meyts, R. Vennekens, B. Bammens

21. Potassium and fibre: a controversial couple in the nutritional management of children with Chronic Kidney Disease. A. El Amouri, K. Delva, A. Foulon, C. Vande Moortel, K. Van Hoeck, G. Glorieux, W. Van Biesen, J. Vande Walle, A. Raes, E. Snauwaert, S. Eloot

22. Impact of COVID-19 on the peritonitis rate in peritoneal dialysis (PD) patients (Pts); a monocentric retrospective study L. Jacobs, J. Nortier, I. Brayer, C. Fosso, M. Mesquita, F. Collart, M. Dratwa

23. Optimised amoxicillin/clavulanic acid dosing in patients on chronic high-flux haemodialysis K. De Schuyter, P.J. Colin, F. Vanommeslaeghe, S. Delanghe, P. De Cock, P. De Paepe, W. Van Biesen, S. Eloot

24. The heterogenous spectrum of nephrotic syndrome in a hiv positive patient: a case report. P Braet, B. Sprangers, P. De Munter

 Info: [email protected]  Website: www.bvn-sbn.be